Kelly Chin
University of Texas Southwestern Medical Center
QC-verified· April 2026 PI on 1 trial
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing dataRare diseases treated or studied
Based on trial PI assignments and publication topics.
Clinical trials (1)
Verify independently
Other specialists for Drug- or toxin-induced pulmonary arterial hypertension
Peers ranked by clinical-trial PI role, publications, and verification quality.
- Andjela Kusic-Pajic, MDActelion
- Eric Austin, MDVanderbilt Medical Center
- Ekkehard Grünig, MDThoraxclinic at the University of Heidelberg
- Nicholas S Hill, MDTufts Medical Center
- Sudarshan Rajagopal, MD, PhD, M.DDuke Health SystemNC
- Richard ArandaGossamer Bio Inc.
- Horst Olschewski, MDMedical University of Graz
- Swee Lay Thein, M.D., MDNational Heart, Lung, and Blood Institute (NHLBI)MD
See all specialists for Drug- or toxin-induced pulmonary arterial hypertension →